Skip to results
Modify your search
NARROW
1-16 of 16
Authors: Alexa B Schrock
Journal Article
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC
The Oncologist, Volume 29, Issue 8, August 2024, Pages e984–e996, https://doi.org/10.1093/oncolo/oyae028
Published: 24 February 2024
Journal Article
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR–Containing Therapy Regimens in Metastatic Colorectal Cancer
The Oncologist, Volume 26, Issue 6, June 2021, Pages 469–475, https://doi.org/10.1002/onco.13679
Published: 10 February 2021
Journal Article
The Pan‐Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA
The Oncologist, Volume 25, Issue 1, January 2020, Pages e39–e47, https://doi.org/10.1634/theoncologist.2018-0528
Published: 11 October 2019
Journal Article
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence
The Oncologist, Volume 25, Issue 1, January 2020, Pages e147–e159, https://doi.org/10.1634/theoncologist.2019-0244
Published: 02 October 2019
Journal Article
FGFR2‐Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
The Oncologist, Volume 24, Issue 11, November 2019, Pages 1462–1468, https://doi.org/10.1634/theoncologist.2019-0121
Published: 27 June 2019
Journal Article
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy
The Oncologist, Volume 24, Issue 10, October 2019, Pages 1340–1347, https://doi.org/10.1634/theoncologist.2019-0034
Published: 30 April 2019
Journal Article
Hybrid Capture‐Based Genomic Profiling Identifies BRAF V600 and Non‐V600 Alterations in Melanoma Samples Negative by Prior Testing
The Oncologist, Volume 24, Issue 5, May 2019, Pages 657–663, https://doi.org/10.1634/theoncologist.2018-0271
Published: 25 January 2019
Journal Article
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy
The Oncologist, Volume 24, Issue 6, June 2019, Pages 791–797, https://doi.org/10.1634/theoncologist.2018-0334
Published: 29 October 2018
Journal Article
Hybrid Capture‐Based Comprehensive Genomic Profiling Identifies Lung Cancer Patients with Well‐Characterized Sensitizing Epidermal Growth Factor Receptor Point Mutations That Were Not Detected by Standard of Care Testing
The Oncologist, Volume 23, Issue 7, July 2018, Pages 776–781, https://doi.org/10.1634/theoncologist.2017-0493
Published: 14 March 2018
Journal Article
ALK Fusions in a Wide Variety of Tumor Types Respond to Anti‐ALK Targeted Therapy
The Oncologist, Volume 22, Issue 12, December 2017, Pages 1444–1450, https://doi.org/10.1634/theoncologist.2016-0488
Published: 04 December 2017
Journal Article
Comprehensive Genomic Profiling of 282 Pediatric Low‐ and High‐Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures
The Oncologist, Volume 22, Issue 12, December 2017, Pages 1478–1490, https://doi.org/10.1634/theoncologist.2017-0242
Published: 04 December 2017
Journal Article
Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA
The Oncologist, Volume 22, Issue 7, July 2017, Pages 774–779, https://doi.org/10.1634/theoncologist.2016-0376
Published: 15 May 2017
Journal Article
Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common CDKN2A Alteration
The Oncologist, Volume 22, Issue 4, April 2017, Pages 416–421, https://doi.org/10.1634/theoncologist.2016-0310
Published: 10 March 2017
Journal Article
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions
The Oncologist, Volume 22, Issue 3, March 2017, Pages 255–263, https://doi.org/10.1634/theoncologist.2016-0279
Published: 16 February 2017
Journal Article
Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
The Oncologist, Volume 21, Issue 11, November 2016, Pages 1306–1314, https://doi.org/10.1634/theoncologist.2016-0148
Published: 28 September 2016
Journal Article
Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization
The Oncologist, Volume 21, Issue 6, June 2016, Pages 762–770, https://doi.org/10.1634/theoncologist.2015-0497
Published: 31 May 2016
